The new 12-month project extends a prior two-year award for which Habegger studied mechanisms of glucagon, Glucagon-like peptide-1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) and ...
G protein-coupled receptors (GPCRs) are essential for cell signal transduction and comprise the largest drug target protein family. Upon agonist stimulation, these receptors activate multiple ...
Researchers found that MASLD, rather than type 2 diabetes alone, was linked to higher fasting glucagon levels in adults with ...
Our easy-to-read fact sheet provides clinicians with an overview of the mechanism of GLP-1 agonists. Our easy-to-read fact sheets provide clinicians with reliable information to share with patients ...
Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...
A new GLP-1 weight loss drug called survodutide has shown promising results in a phase 3 clinical trial. The drug, which ...
Severe hypoglycemia (low blood sugar) can cause people with diabetes to have seizures or lose consciousness, which can make it impossible to treat low blood sugar by eating or drinking something ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results